“…A higher uptake of HEDICINs 8, as compared to HECINs 9, could arise from: a) a more efficient transport by passive diffusion, as HEDICINs are more lipophilic than HECINs; globally, HEDICINs and HECINs have similar acidebase properties (average estimated pKa w 4 for deprotonation of the quinolinic nitrogen), but differ by almost two units in their estimated logP values (4.2 < logP < 5.1 for HECINs; 5.8 < log P < 7.9 for HEDICINs; cf. Table 1) [33], with the most lipophilic, 8c, being also the most active anti-plasmodial; amino acid and dipeptide esters are known to cross cell membranes by passive diffusion [38], so it is possible that the presence of the dipeptide spacer in HEDICINs augments cell permeation of these compounds by such process; b) recognition of the dipeptide motif by specific transporters from the P. falciparum ABC transporter super-family, many of which have been taken as putative drug transporting proteins [39] and found to be directly implicated in drugresistance mechanisms [40,41]; c) increased permeability of dipeptide derivatives due to the new permeation pathways created in P. falciparum-infected RBCs to promote uptake of nutrients such as sugars or nucleosides [42], as well as amino acids and oligopeptides [31]; II. Alternatively, a difference in the respective mechanism of action (MOA) may be operating in addition, or in alternative, to a difference in uptake of HEDICINs versus HECINs: a) due to their dipeptide moiety, HEDICINs might be able to inhibit plasmodial cytosolic proteases like aminopeptidases PfA-M1 and PfA-M17, which function in regulating the intracellular pool of amino acids required for parasite growth and development inside the red blood cell [43,44]; b) HEDICINs anti-plasmodial activity could otherwise be related to the cinnamoyl moiety, as it has been shown that cinnamic acid derivatives inhibit the growth of intraerythrocytic P. falciparum in culture by inhibiting monocarboxylate (e.g.…”